Schizophrenia Disorder

DecNef for AVH in Schizophrenia

A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants With Schizophrenia

dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia

Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia

Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

Inter-Brain Synchrony in Schizophrenia

Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia

An Expanded Access Program (EAP) for OLZ/SAM in Pediatric Participants With Schizophrenia or Bipolar I Disorder (ALKS 3831-315)

Cognitive Strategies in Early Psychosis 2

TIS for Improving Cognitive Impairment in Schizophrenia

MicroRNAs as Biomarkers in First Episode Schizophrenia

Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression

A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

Virtual Reality-Based Smoking Cessation Treatment in Patients With Schizophrenia

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

Medication Adherence in Severe Mental Illness: a Promotion Program

LRFN5 and OLFM4 in Schizophrenia